Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

A multi-route model of nicotine-cotinine pharmacokinetics, pharmacodynamics and brain nicotinic acetylcholine receptor binding in humans.

Teeguarden JG, Housand CJ, Smith JN, Hinderliter PM, Gunawan R, Timchalk CA.

Regul Toxicol Pharmacol. 2013 Feb;65(1):12-28. doi: 10.1016/j.yrtph.2012.10.007. Epub 2012 Oct 23.

PMID:
23099439
2.

Smoking behaviour and compensation: a review of the literature.

Scherer G.

Psychopharmacology (Berl). 1999 Jul;145(1):1-20. Review.

PMID:
10445368
3.

The possible role of ammonia toxicity on the exposure, deposition, retention, and the bioavailability of nicotine during smoking.

Seeman JI, Carchman RA.

Food Chem Toxicol. 2008 Jun;46(6):1863-81. doi: 10.1016/j.fct.2008.02.021. Epub 2008 Mar 4. Review.

PMID:
18450355
4.

[Toxicologic and pharmacologic methods in the control of smoking behavior].

Ackermann E.

Z Erkr Atmungsorgane. 1989;173(2):127-33. Review. German.

PMID:
2686221
5.

Nicotine addiction: insights from recent animal studies.

Mathieu-Kia AM, Kellogg SH, Butelman ER, Kreek MJ.

Psychopharmacology (Berl). 2002 Jul;162(2):102-18. Epub 2002 May 15. Review.

PMID:
12110988
6.

Nicotine chemistry, metabolism, kinetics and biomarkers.

Benowitz NL, Hukkanen J, Jacob P 3rd.

Handb Exp Pharmacol. 2009;(192):29-60. doi: 10.1007/978-3-540-69248-5_2. Review.

7.

α7 nicotinic acetylcholine receptor subunit in angiogenesis and epithelial to mesenchymal transition.

Pillai S, Chellappan S.

Curr Drug Targets. 2012 May;13(5):671-9. Review.

PMID:
22300034
8.

Angiogenic activity of nicotinic acetylcholine receptors: implications in tobacco-related vascular diseases.

Egleton RD, Brown KC, Dasgupta P.

Pharmacol Ther. 2009 Feb;121(2):205-23. doi: 10.1016/j.pharmthera.2008.10.007. Epub 2008 Nov 14. Review.

PMID:
19063919
9.

Tobacco smoking and nicotine neuropsychopharmacology: some future research directions.

Domino EF.

Neuropsychopharmacology. 1998 Jun;18(6):456-68. Review.

10.

Reevaluating the nicotine delivery kinetics hypothesis.

Dar R, Frenk H.

Psychopharmacology (Berl). 2007 May;192(1):1-7. Epub 2007 Apr 3. Review.

PMID:
17404711
11.

Pharmacogenetics of nicotine and associated smoking behaviors.

Tanner JA, Chenoweth MJ, Tyndale RF.

Curr Top Behav Neurosci. 2015;23:37-86. doi: 10.1007/978-3-319-13665-3_3. Review.

PMID:
25655887
12.

Imaging the neurochemistry of nicotine actions: studies with positron emission tomography.

Volkow ND, Fowler JS, Ding YS, Wang GJ, Gatley SJ.

Nicotine Tob Res. 1999;1 Suppl 2:S127-32; discussion S139-40. Review.

PMID:
11768169
13.

Nicotine and inflammatory neurological disorders.

Piao WH, Campagnolo D, Dayao C, Lukas RJ, Wu J, Shi FD.

Acta Pharmacol Sin. 2009 Jun;30(6):715-22. doi: 10.1038/aps.2009.67. Epub 2009 May 18. Review.

14.

Brain imaging and the effects of caffeine and nicotine.

Dager SR, Friedman SD.

Ann Med. 2000 Dec;32(9):592-9. Review.

PMID:
11209966
15.
16.

Facts about nicotine toxicity.

Karaconji IB.

Arh Hig Rada Toksikol. 2005 Dec;56(4):363-71. Review.

PMID:
16370520
17.

The effects of nicotine on metabolic rate.

Marks BL, Perkins KA.

Sports Med. 1990 Nov;10(5):277-85. Review. No abstract available.

PMID:
2263796

Supplemental Content

Support Center